摘要
目的：探讨脑梗死患者接受依达拉奉与舒血宁联合治疗的临床效果。方法2012年9月-2014年9月我院对82例脑梗死患者进行研究分析，将患者分成对照组和治疗组，均有41例。对照组患者接受依达拉奉治疗，治疗组使用依达拉奉与舒血宁联合治疗。结果治疗组患者临床中接受药物治疗后神经功能缺损评分改善情况比对照组优秀。结论脑梗死患者临床中接受依达拉奉与舒血宁联合治疗的临床效果比较突出。
ObjectiveTo investigate the clinical effect in patients with cerebral infarction received combination therapy of edaravone and Shuxuening injection. MethodsFrom September 2012 to September 2014,82 patients with cerebral infarction were studied and analyzed. The patients were divided into two groups： control group and treatment group,with 41 cases in our hospital. The control group received edaravone treatment,the treatment group used edaravone combined therapy with Shuxuening injection.ResultsIn the treatment group,the scores of neurological deficits after drug treatment were better than those of the control group. ConclusionThe clinical effect of Shuxuening combined with edaravone in patients with cerebral infarction are more prominent.
出处
《中国卫生标准管理》
2016年第17期125-126,共2页
China Health Standard Management
关键词
依达拉奉
舒血宁
脑梗死
治疗
Edaravone
Shuxuening injection
Cerebral infarction
Treatment
